author-photo

E. Felip

Hebron University

174

Papers

1900

Citations

Citation Trend

Filter By

Papers (114) Sort By

Journal Conference Others

1231P Characterization and management of mobocertinib (TAK-788) induced skin toxicity in patients with EGFR exon 20 insertion+ (ex20ins+) non-small cell lung cancer (NSCLC) who previously received platinum chemotherapy

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
MA11.08 Patient-Reported Outcomes from the Randomized Phase 3 CROWN Study of First-Line Lorlatinib versus Crizotinib in ALK+ NSCLC

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
MA04.07 Clinical Characteristics and Outcomes in Patients With Malignant Pleural Mesothelioma (MPM) with COVID-19 Infection

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract S01-03: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
1193MO Amivantamab plus lazertinib in post-osimertinib, post-platinum chemotherapy EGFR-mutant non-small cell lung cancer (NSCLC): Preliminary results from CHRYSALIS-2

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
126P Clinical predictive factors in real world setting in advanced non-small cell lung cancer (NSCLC) patients (pts)treated with immune checkpoint inhibitors (ICI)

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Patient-Reported Outcomes from the Randomized Phase 3 CROWN Study of First-Line Lorlatinib versus Crizotinib in ALK plus NSCLC

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection: the OnCovid inflammatory score

2021
Show All
- Source
- Cite
- Save
Citations (0)
Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non–Small-Cell Lung Cancer

2021
Show All
- Source
- Cite
- Save
Citations (4)
198P Analysis of efficacy of immunotherapy according to histology in malignant pleural mesothelioma (MPM) patients

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)